Access in all areas? A round up of developments in market access and health technology assessment: part 3

In this latest update, we explore some of the key updates in market access over recent months including the UK's voluntary scheme for branded medicines pricing, access and growth (VPAG), the first drugs funded by the Innovative Medicines Fund in the UK and the Direct Access Scheme in France, an...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of comparative effectiveness research 2024-03, Vol.13 (3), p.e240009-e240009
Hauptverfasser:	Beattie, Alice, Treharne, Catrin, Ramagopalan, Sreeram V
Format:	Artikel
Sprache:	eng
Schlagworte:	canadian drug agency direct access scheme health technology assessment health technology management icer Industry Update innovative medicines fund market access value assessment framework vpag
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	In this latest update, we explore some of the key updates in market access over recent months including the UK's voluntary scheme for branded medicines pricing, access and growth (VPAG), the first drugs funded by the Innovative Medicines Fund in the UK and the Direct Access Scheme in France, and, finally, the new Institute for Clinical and Economic Review (ICER) value assessment framework in the USA.
ISSN:	2042-6305 2042-6313
DOI:	10.57264/cer-2024-0009